Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SIRT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02719899
What this trial is testing

Effect of Fasting and Refeeding on T-cell Fate

Who this might be right for
AsthmaInflammation
National Heart, Lung, and Blood Institute (NHLBI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06397222
What this trial is testing

Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 23
Not applicableStudy completedNCT03753451
What this trial is testing

Influence of Periodontal Disease Treatment on Serum Levels of Sirtuin 1 and Mannose-binding Lectin

Who this might be right for
Periodontal Diseases
InCor Heart Institute 80
Not applicableUnknownNCT02783261
What this trial is testing

Prospective Post Y90 Liver Hypertrophy

Who this might be right for
Hepatocellular CarcinomaLiver Hypertrophy
Singapore General Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT03565328
What this trial is testing

The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects

Who this might be right for
Heart Failure
National Heart, Lung, and Blood Institute (NHLBI) 2
Testing effectiveness (Phase 2)Study completedNCT02167711
What this trial is testing

Treatment for Bile Duct Cancer in the Liver

Who this might be right for
Cholangio Carcinoma
Chinese University of Hong Kong 24
Testing effectiveness (Phase 2)UnknownNCT01798147
What this trial is testing

Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).

Who this might be right for
Intrahepatic Cholangiocellular Carcinoma
Johannes Gutenberg University Mainz 24
Not applicableStudy completedNCT02840981
What this trial is testing

Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Subjects

Who this might be right for
Mediterranean DietNutritionSirtuin 4+1 more
Federico II University 43
Not applicableUnknownNCT05808387
What this trial is testing

The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers

Who this might be right for
Coronary Artery DiseaseMenopauseEndothelial Dysfunction
InCor Heart Institute 80
Not applicableLooking for participantsNCT06910722
What this trial is testing

Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy

Who this might be right for
Intrahepatic CholangiocarcinomaLocally Advanced Intrahepatic Cholangiocarcinoma
Assistance Publique - Hôpitaux de Paris 36
Testing effectiveness (Phase 2)UnknownNCT00436267
What this trial is testing

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

Who this might be right for
Metastatic CancerPancreatic Cancer
Goshen Health System 20
Early research (Phase 1)Active Not RecruitingNCT05701488
What this trial is testing

SIRT With Tremelimumab and Durvalumab for Resectable HCC

Who this might be right for
Resectable Hepatocellular CarcinomaHepatocellular CarcinomaHepatocellular Cancer
Jiping Wang, MD, PhD 20
Testing effectiveness (Phase 2)Study completedNCT03380130
What this trial is testing

The Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Clinica Universidad de Navarra, Universidad de Navarra 41
Not applicableUnknownNCT04137406
What this trial is testing

Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis

Who this might be right for
Breast CancerLymph Node Metastases
Peking University People's Hospital 160
Not applicableLooking for participantsNCT07476651
What this trial is testing

Scout Dose of Resin Microspheres

Who this might be right for
RadioembolizationHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)+1 more
Seoul National University Hospital 30
Not applicableUnknownNCT00978640
What this trial is testing

Sirtuin Mediated Effects of 36 Hour Fast and 1 Hour Exercise

Who this might be right for
Healthy
University of Aarhus 8
Testing effectiveness (Phase 2)Looking for participantsNCT06707233
What this trial is testing

Y-90 SIRT for Unresectable HCC Larger Than 7cm

Who this might be right for
Hepatocellular Carcinoma Non-Resectable
Second Affiliated Hospital of Guangzhou Medical University 33
Not applicableStudy completedNCT01668836
What this trial is testing

Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years

Who this might be right for
Vascular System InjuriesLipid Metabolism DisordersEndothelial Disfunction
InCor Heart Institute 48
Not applicableEnrolling By InvitationNCT07617038
What this trial is testing

OE MRI to Predict Treatment Response After TACE in HCC Patients

Who this might be right for
HCC - Hepatocellular CarcinomaTACESIRT
Université de Montréal 60
Testing effectiveness (Phase 2)Study completedNCT02195011
What this trial is testing

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Neoplasms
SCRI Development Innovations, LLC 26
Next Page